Clinical Trial Update: Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intrathecal autologous adipose-derived mesenchymal stromal cells for ALS has posted results; the trial is listed as active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Intrathecal autologous adipose-derived mesenchymal stromal cells (adipose-derived mesenchymal stromal cells)

Snippet

Sponsor: Mayo Clinic | Conditions: ALS, Amyotrophic Lateral Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-02